NVS (NVS) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $165.53
• Market Cap: $322.53B
• P/E Ratio: 23.30
• EPS: $7.16
• Dividend Yield: 0.03%
• 52-Week High: $168.02
• 52-Week Low: $97.72

Market Sentiment

NVS currently has a Bullish sentiment score of 0.41.

About NVS

Novartis AG (ADR) is a premier global healthcare company headquartered in Basel, Switzerland, dedicated to the research, development, manufacturing, and marketing of innovative pharmaceuticals and medical devices. Renowned for its robust portfolio of patented treatments across critical therapeutic areas such as oncology, cardiology, and immunology, Novartis leverages cutting-edge science to enhance patient outcomes. The company's strong focus on research and development, along with strategic ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for NVS and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is NVS's current dividend yield?

NVS (NVS) has a current dividend yield of 0.03%.

Does NVS pay dividends?

Yes, NVS pays dividends with a current yield of 0.03%.

What is NVS's P/E ratio?

NVS has a price-to-earnings (P/E) ratio of 23.30.

What is NVS's market cap?

NVS (NVS) has a market capitalization of $322.53B with a current stock price of $165.53.